Experience of Long-Term Afala Treatment in Benign Prostatic Hyperplasia

被引：3
作者：
Gudkov, A. V. [1 ]
机构：
[1] Siberian State Med Univ, Fed Agcy Hlth Care & Social Dev, Tomsk, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2009年 / 148卷 / 02期
关键词：
adenoma of the prostate; benign prostatic hyperplasia; afala; LUTS;
D O I：
10.1007/s10517-009-0695-8
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The use of ultralow doses of antibodies to prostate-specific antigen (afala) for long-term treatment of benign prostatic hyperplasia in patients with moderate symptoms rapidly and effectively reduces irritative and obstructive symptoms, significantly decreases residual urine volume, and increases the rate of urination. Afala therapy is indicated for patients with stage I-II benign prostatic hyperplasia of moderately pronounced symptoms.
引用
收藏
页码：308 / 311
页数：4
相关论文
共 50 条
  • [31] Individualization of treatment in benign prostatic hyperplasia
    Altwein, JE
    EUROPEAN UROLOGY, 1996, 29 : 2 - 6
  • [32] Dutasteride for the treatment of benign prostatic hyperplasia
    Wu, Christopher
    Kapoor, Anil
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (10) : 1399 - 1408
  • [33] Pharmacological treatment of benign prostatic hyperplasia
    Oelke, M.
    Kuczyk, M. A.
    Herrmann, T. R. W.
    UROLOGE, 2009, 48 (11): : 1365 - 1375
  • [34] Phytotherapy in the treatment of benign prostatic hyperplasia
    Bracher, F
    UROLOGE-AUSGABE A, 1997, 36 (01): : 10 - 17
  • [35] Tadalafil for the treatment of benign prostatic hyperplasia
    Monica, Fabiola Zakia
    De Nucci, Gilberto
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (08) : 929 - 937
  • [36] Options for the Treatment of Benign Prostatic Hyperplasia
    Plante, Mark
    Wachterman, Jared
    Perrapato, Scott
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2012, 22 (04): : 281 - 287
  • [37] Pharmacological treatment of benign prostatic hyperplasia
    Oelke, M.
    Martinelli, E.
    UROLOGE, 2016, 55 (01): : 81 - 94
  • [38] Association of the Benign Prostatic Hyperplasia and erectile dysfunction, the current treatment modalities in Benign Prostatic Hyperplasia
    Sen, Volkan
    Demir, Omer
    Esen, Ahmet Adil
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (04): : 62 - 64
  • [39] Medical Treatment of Benign Prostatic Hyperplasia
    Plochocki, Alexander
    King, Benjamin
    UROLOGIC CLINICS OF NORTH AMERICA, 2022, 49 (02) : 231 - 238
  • [40] Role of mpMRI in Benign Prostatic Hyperplasia Assessment and Treatment
    Stephanie M. Walker
    Baris Turkbey
    Current Urology Reports, 2020, 21
12345